Clinical Trial Update: Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade [Phase 2]

View source ↗

Summary

Phase 2 trial investigating biomarkers to identify HER2 dependence in HER2-positive early breast cancer to de-escalate neoadjuvant chemotherapy while using HER2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING